{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:39Z","timestamp":1787004819907,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jrnjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1053\/j.jrn.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T07:22:32Z","timestamp":1459408952000},"page":"265-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients"],"prefix":"10.1053","volume":"26","author":[{"given":"Jennifer","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc-Tram Gia","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elani","family":"Streja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Pahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2016.02.006_bib1","series-title":"2012 Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2012"},{"key":"10.1053\/j.jrn.2016.02.006_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/15701611113119990025","article-title":"Clinical uses of 1-alpha-hydroxy-ergocalciferol","volume":"12","author":"Park","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1053\/j.jrn.2016.02.006_bib3","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/ki.2010.189","article-title":"Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals","author":"Kalantar-Zadeh","year":"2010","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2016.02.006_bib4","series-title":"2008 Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2008"},{"key":"10.1053\/j.jrn.2016.02.006_bib5","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol","volume":"38","author":"Sprague","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.02.006_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.02.006_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/ajkd.1998.v32.pm9808139","article-title":"Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure","volume":"32","author":"Llach","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.02.006_bib8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with ESRD who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2016.02.006_bib9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(68)91816-3","article-title":"Arterial calcification after vitamin D therapy in hyperphosphatemic renal failure","volume":"2","author":"Mallick","year":"1968","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2016.02.006_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.02.006_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2016.02.006_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ndt\/17.suppl_10.10","article-title":"Vitamin D analogues for secondary hyperparathyroidism","volume":"17","author":"Brown","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2016.02.006_bib13","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1053\/ajkd.1998.v32.pm9808145","article-title":"Therapy of secondary hyperparathyroidism with 10 nor-1alpha, 25-dihydroxyvitamin D2","volume":"32","author":"Martin","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.02.006_bib14","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2016.02.006_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2016.02.006_bib16","first-page":"1","article-title":"Evaluating targets and\u00a0costs of treatment for secondary hyperparathyroidism in incident dialysis\u00a0patients: the FARO-2 study","volume":"8","author":"Roggeri","year":"2015","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1053\/j.jrn.2016.02.006_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40261-013-0151-4","article-title":"Cost Effectiveness of paricalcitol versus cinacalcet plus low-dose vitamin D therapy for management of secondary hyperparathyroidism in haemodialysis patients in the USA","volume":"34","author":"Sharma","year":"2014","journal-title":"Clin Drug Investig"},{"key":"10.1053\/j.jrn.2016.02.006_bib18","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/ndt\/gfs018","article-title":"Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: result of the IMPACT SHPT study","volume":"19","author":"Ketteler","year":"2012","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227616000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227616000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T18:26:52Z","timestamp":1536863212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227616000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1051227616000455"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2016.02.006","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}